d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund